EcoDrugPlus

Ensembl ID : ENSLCAG00010023235
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSLCAG00010022514
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSLCAG00010020283
Gene Symbol: -
1 Cross references
352 Possible Orthologues:

Ensembl ID : ENSLCAG00010026485
Gene Symbol: -
Cross references: -
175 Possible Orthologues:

Ensembl ID : ENSLCAG00010019269
Gene Symbol: -
Cross references: -
332 Possible Orthologues:

Ensembl ID : ENSLCAG00010026526
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSLCAG00010018024
Gene Symbol: -
Cross references: -
358 Possible Orthologues:

Ensembl ID : ENSLCAG00010026236
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSLCAG00010014414
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSLCAG00010018410
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSLCAG00010015546
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSLCAG00010020285
Gene Symbol: -
1 Cross references
352 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).